16:28 EST Ionis Pharmaceuticals (IONS) trading halted, news pending
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONS:
- Ionis Pharmaceuticals management to meet with Oppenheimer
- Theratechnologies enters exclusive licensing agreement with Ionis
- Ionis added to Analyst Current Favorites list at Raymond James
- Ionis Pharmaceuticals price target lowered to $62 from $65 at Piper Sandler
- Ionis Pharmaceuticals price target lowered to $77 from $82 at Wells Fargo